Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-02-27 00:00:00 ET · period of report 2025-02-25 · accession 0000950170-25-029262 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-02-27 | 2025-02-25 | BBIO | STEPHENSON BRIAN C | CFO, Treas | S - Sale+OE | $33.19 | -8,500 | 102.5K | -8% | -$282.1K |
| DT | 2025-02-27 | 2025-02-25 | BBIO | STEPHENSON BRIAN C | CFO, Treas | M - OptEx | $17.00 | +8,500 | 111.0K | +8% | +$144.5K |
| DT | 2025-02-27 | 2025-02-25 | BBIO | STEPHENSON BRIAN C | CFO, Treas | M - OptEx | $0.00 | -8,500 | 440.2K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | S | D | 8,400 | $33.18 | 102,564 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $32.63 to $33.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-02-25 | S | D | 100 | $34.18 | 102,464 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-25 | M | A | 8,500 | $17.00 | 110,964 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2025-02-25 | M | D | 8,500 | $0.00 | 440,170 | D | $17.00 · — to 2029-06-26 | 8,500 Common Stock | (F3) The shares subject to this option vested in 48 equal monthly installments from June 26, 2019 to June 26, 2023. |